Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CellCept for Refractory Interstitial Cystitis
NCT00451867Phase 3Terminated
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Mar 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of mycophenolate mofetil in interstitial cystitis (IC), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Mar 2007; status: terminated.
02
Drugs
mycophenolate mofetil
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT00451867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451867.